Sign In

Biotechnology

       To realize the promise of Biotechnology in health, energy, environment, and food requires a reliable, global IP system that rewards innovation without inhibiting it and protects investments in new products and new jobs.  Biotechnology IP practitioners and companies, however, face very significant challenges in helping the world realize this promise.  The overall mission of the Biotechnology Committee is to serve as resource, educator, and advocate for its members, AIPLA, government institutions, and people everywhere so that the promise of Biotechnology may be more fully realized globally.

 

​
Jim Kelley, Eli Lilly and Company, Chair
Carol Nielsen, Nielsen IP Law LLC, Vice Chair
Mercedes K. Meyer, Drinker Biddle & Reath LLP, Board Liaison​
​
MEMBER SERVICES
 
Program Development
Tim Meigs,
Co-Chair, meetings
Lynn Tyler,
Co-chair, webinars
 
Biotech Buzz
Dan Lev,
Chair
Noel Courage,
Vice-Chair
 
Case Law
Melanie Szweras,
Chair
Nicholas Landau,
Vice Chair
 
USPTO Relations
Suzannah Sundby,
Co-Chair
Julie Meigs,
Co-Chair
 
Microsite
William Childs,
Chair
 
 
Diagnostics and Gene Patenting
Co-Chair
Co-Chair
 
Biological Product Development and Competition (Proposed)
Co-Chair
Co-Chair
Co-Chair
 
Biotech Tech Transfer & Licensing (Proposed)
Co-Chair
Co-Chair
GLOBAL OUTREACH
 
International Issues
Chair
Vice Chair, Far East, China, Japan, India
Vice Chair, Latin America
Vice Chair, Europe
Vice Chair, Canada, Australia
 
Liaisons:
China:  Li Feng
Europe: TBD
Far East: TBD
International: TBD
Latin America:  Benny Spiewak

 

ADVOCACY
  
Global Advocacy
Jim Kelley, Chair
Carol Nielsen, Vice Chair
Liaison with Amicus: Dave Cupar​
​
 ​
 PUBLIC EDUCATION
 
Biotech Patent Education
Karen Canady, Chair
Liaison with Public Education: TBD
​
 
 
 

 Committee Announcements

 
TitleUse SHIFT+ENTER to open the menu (new window).
  
Announcement Description
  

To illustrate and study the diversity of utility standards across a range of jurisdictions, the committee has put together a FREE one-day symposium with speakers who are experts in US, European, Canadian, Japanese, and international patent laws will compare
and contrast the utility requirements for patents in the various jurisdictions, including:

1) statutory and treaty-based requirements;
2) interpretation of those requirements by
courts;
3) evidentiary requirements for demonstrating
utility; and
4) discussion of recent cases that illustrate
comparable and divergent approaches.

The program will be held at the University of Ottowa.
 

 

  

Webinar, December 6, 12:30 EST: "Obtaining and Enforcing Patents on Bioinformatic and Diagnostic Inventions."
On December 6, at 12:30 pm Eastern time, the Committee is presenting a webinar titled, "Obtaining and Enforcing Patents on Bioinformatic and Diagnostic Inventions." The webinar will be a reprise of presentations given at the AIPLA Annual Meeting by Jim Kelley of Eli Lilly and Company, Judy Roesler of Roesler Law Offices, and Ling Zhong of RatnerPrestia and will discuss recent developments in the law under Sections 101 and 112 and their impact on patenting strategies in bioinformatics and diagnostics. Please note that there is no cost to attend this webinar and CLE credit is not available. We hope you can join us!
 

Many thanks to our sponsors, Barnes & Thornburg LLP and RatnerPrestia!
​
 

 Committee Calendar

 
< May, 2012 >
 Sun  Mon  Tue  Wed  Thu  Fri  Sat 
 29 
  30 
  1 
  2 
  3 
  4 
  5 
 6 
  7 
  8 
  9 
  10 
  11 
  12 
 13 
  14 
  15 
  16 
  17 
  18 
  19 
 20 
  21 
  22 
  23 
  24 
  25 
  26 
 27 
  28 
  29 
  30 
  31 
  1 
  2